Decrease of Invasive Pneumococcal Infections in Children Among 8 Childrens Hospitals in the United States After the Introduction of the 7-Valent Pneumococcal Conjugate Vaccine




* Pediatric Infectious Diseases Sections of the Baylor College of Medicine, Houston, Texas
University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
University of Arkansas for Medical Sciences, Little Rock, Arkansas
|| Childrens Hospital San Diego, San Diego, California
¶ Northwestern University Medical School, Chicago, Illinois
# University of Southern California School of Medicine, Los Angeles, California
** Wake Forest University School of Medicine, Winston-Salem, North Carolina

Ohio State University College of Medicine and Public Health, Columbus, Ohio
Objective. To monitor clinical and microbiologic features including antimicrobial susceptibility and serogroup distribution of invasive infections caused by Streptococcus pneumoniae among children before and after the introduction of routine administration of the 7-valent pneumococcal conjugate vaccine (PCV7).
Design. A 9-year (January 1, 1994 through December 31, 2002) prospective surveillance study of all invasive pneumococcal infections in children.
Patients. Infants and children cared for at 8 childrens hospitals in the United States with culture-proven invasive infections caused by S pneumoniae.
Results. When compared with the mean of the years 1994 to 2000, the annual number of invasive pneumococcal infections for children
24 months of age declined 58% in 2001 and 66% in 2002. If only the serogroups in the PCV7 are considered, the number of cases in children
24 months old declined 63% and 77% in 2001 and 2002, respectively. The greatest decrease was observed for serogroup-14 isolates. The number of isolates in nonvaccine serogroups increased 28% in 2001 and 66% in 2002 for children
24 months old. Nonvaccine serogroup-15 and -33 isolates had the greatest increase in number. The proportion of all isolates nonsusceptible to penicillin increased yearly from 1994 to 2000, reached a plateau in 2001 at 45%, and declined to 33% in 2002. Decrease in nonsusceptibility to penicillin occurred entirely in the isolates with penicillin minimum inhibitory concentration
2 µg/mL. Nonsusceptibility to penicillin increased slightly among nonvaccine-serotype isolates. Most infections after at least 2 doses of PCV7 were caused by nonvaccine-serotype isolates.
Conclusions. Since the introduction of the PCV7, the number of invasive pneumococcal infections caused by vaccine-serogroup isolates among 8 US childrens hospitals has decreased >75% among children
24 months old. In addition, penicillin resistance decreased in 2002 for the first time since our surveillance began in 19931994. However, we have noted that replacement may be developing with serogroups 15 and 33. Furthermore, penicillin resistance seems to be increasing among nonvaccine serogroups. Surveillance must be continued to detect the emergence of changes in the distribution of serotypes as well as antibiotic susceptibility.
Key Words: Streptococcus pneumoniae conjugate vaccine surveillance
Abbreviations: PCV7, 7-valent pneumococcal conjugate vaccine CDC, Centers for Disease Control and Prevention ABC, Active Bacterial Core HIV, human immunodeficiency virus
Received for publication Sep 15, 2003; Accepted Nov 6, 2003.
![]()
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
C. Tsigrelis, I. M. Tleyjeh, W. C. Huskins, B. D. Lahr, L. M. Nyre, A. Virk, and L. M. Baddour Incidence of Invasive Pneumococcal Disease Among Children After Introduction of a 7-Valent Pneumococcal Conjugate Vaccine: A Population-Based Study in Olmsted County, Minnesota Mayo Clin. Proc., October 1, 2009; 84(10): 871 - 875. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Kanegaye, L. E. Nigrovic, R. Malley, C. R. Cannavino, S. H. Schwab, J. E. Bennett, M. M. Mohseni, V. J. Wang, Y. L. Katsogridakis, M. I. Herman, et al. Diagnostic Value of Immature Neutrophils (Bands) in the Cerebrospinal Fluid of Children With Cerebrospinal Fluid Pleocytosis Pediatrics, June 1, 2009; 123(6): e967 - e971. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Stancil, T. R. Peters, L. B. Givner, and K. A. Poehling Potential Impact of Accelerating the Primary Dose of Pneumococcal Conjugate Vaccine in Infants Arch Pediatr Adolesc Med, May 1, 2009; 163(5): 422 - 425. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Alter Pneumococcal Infections Pediatr. Rev., May 1, 2009; 30(5): 155 - 164. [Full Text] [PDF] |
||||
![]() |
F. Mahjoub-Messai, C. Doit, J.-L. Koeck, T. Billard, B. Evrard, P. Bidet, C. Hubans, J. Raymond, C. Levy, R. Cohen, et al. Population Snapshot of Streptococcus pneumoniae Serotype 19A Isolates before and after Introduction of Seven-Valent Pneumococcal Vaccination for French Children J. Clin. Microbiol., March 1, 2009; 47(3): 837 - 840. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Waddle and R Jhaveri Outcomes of febrile children without localising signs after pneumococcal conjugate vaccine Arch. Dis. Child., February 1, 2009; 94(2): 144 - 147. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. E. Hsu, K. A. Shutt, M. R. Moore, B. W. Beall, N. M. Bennett, A. S. Craig, M. M. Farley, J. H. Jorgensen, C. A. Lexau, S. Petit, et al. Effect of Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis N. Engl. J. Med., January 15, 2009; 360(3): 244 - 256. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Kimia, A. J. Capraro, D. Hummel, P. Johnston, and M. B. Harper Utility of Lumbar Puncture for First Simple Febrile Seizure Among Children 6 to 18 Months of Age Pediatrics, January 1, 2009; 123(1): 6 - 12. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Pichichero, J. R. Casey, A. Hoberman, and R. Schwartz Pathogens Causing Recurrent and Difficult-to-Treat Acute Otitis Media, 2003-2006 Clinical Pediatrics, November 1, 2008; 47(9): 901 - 906. [Abstract] [PDF] |
||||
![]() |
L. S. Eiland Increasing Prevalence of Pneumococcal Serotype 19A Among US Children Journal of Pharmacy Practice, October 1, 2008; 21(5): 356 - 362. [Abstract] [PDF] |
||||
![]() |
C. Azzari, M. Moriondo, G. Indolfi, C. Massai, L. Becciolini, M. de Martino, and M. Resti Molecular detection methods and serotyping performed directly on clinical samples improve diagnostic sensitivity and reveal increased incidence of invasive disease by Streptococcus pneumoniae in Italian children J. Med. Microbiol., October 1, 2008; 57(10): 1205 - 1212. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. Critchley, M. R. Jacobs, S. D. Brown, M. M. Traczewski, G. S. Tillotson, and N. Janjic Prevalence of Serotype 19A Streptococcus pneumoniae among Isolates from U.S. Children in 2005-2006 and Activity of Faropenem Antimicrob. Agents Chemother., July 1, 2008; 52(7): 2639 - 2643. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ongkasuwan, T. A. Valdez, K. G. Hulten, E. O. Mason Jr, and S. L. Kaplan Pneumococcal Mastoiditis in Children and the Emergence of Multidrug-Resistant Serotype 19A Isolates Pediatrics, July 1, 2008; 122(1): 34 - 39. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Jacobs, C. E. Good, B. Beall, S. Bajaksouzian, A. R. Windau, and C. G. Whitney Changes in Serotypes and Antimicrobial Susceptibility of Invasive Streptococcus pneumoniae Strains in Cleveland: a Quarter Century of Experience J. Clin. Microbiol., March 1, 2008; 46(3): 982 - 990. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Dubos, I Marechal, M O Husson, C Courouble, M Aurel, A Martinot, and the Hospital Network for Evaluating the Management Decline in pneumococcal meningitis after the introduction of the heptavalent-pneumococcal conjugate vaccine in northern France Arch. Dis. Child., November 1, 2007; 92(11): 1009 - 1012. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Rajam, G. M. Carlone, and S. Romero-Steiner Functional Antibodies to the O-Acetylated Pneumococcal Serotype 15B Capsular Polysaccharide Have Low Cross-Reactivities with Serotype 15C Clin. Vaccine Immunol., September 1, 2007; 14(9): 1223 - 1227. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Golnik Pneumococcal Meningitis Presenting With a Simple Febrile Seizure and Negative Blood-Culture Result Pediatrics, August 1, 2007; 120(2): e428 - e431. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Melegaro, Y. Choi, R. Pebody, and N. Gay Pneumococcal Carriage in United Kingdom Families: Estimating Serotype-specific Transmission Parameters from Longitudinal Data Am. J. Epidemiol., July 15, 2007; 166(2): 228 - 235. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Basset, K. Trzcinski, C. Hermos, K. L. O'Brien, R. Reid, M. Santosham, A. J. McAdam, M. Lipsitch, and R. Malley Association of the Pneumococcal Pilus with Certain Capsular Serotypes but Not with Increased Virulence J. Clin. Microbiol., June 1, 2007; 45(6): 1684 - 1689. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Singleton, T. W. Hennessy, L. R. Bulkow, L. L. Hammitt, T. Zulz, D. A. Hurlburt, J. C. Butler, K. Rudolph, and A. Parkinson Invasive Pneumococcal Disease Caused by Nonvaccine Serotypes Among Alaska Native Children With High Levels of 7-Valent Pneumococcal Conjugate Vaccine Coverage JAMA, April 25, 2007; 297(16): 1784 - 1792. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Rand, L. P. Shone, C. Albertin, P. Auinger, J. D. Klein, and P. G. Szilagyi National Health Care Visit Patterns of Adolescents: Implications for Delivery of New Adolescent Vaccines Arch Pediatr Adolesc Med, March 1, 2007; 161(3): 252 - 259. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Nigrovic, N. Kuppermann, C. G. Macias, C. R. Cannavino, D. M. Moro-Sutherland, R. D. Schremmer, S. H. Schwab, D. Agrawal, K. M. Mansour, J. E. Bennett, et al. Clinical Prediction Rule for Identifying Children With Cerebrospinal Fluid Pleocytosis at Very Low Risk of Bacterial Meningitis JAMA, January 3, 2007; 297(1): 52 - 60. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Abuelreish, A. Subedar, T. Chiu, P. Wludyka, and M. Rathore Increase in Invasive Pneumococcal Disease in Children Associated With Shortage of Heptavalent Pneumococcal Conjugate Vaccine Clinical Pediatrics, January 1, 2007; 46(1): 45 - 52. [Abstract] [PDF] |
||||
![]() |
P. G. Szilagyi, M. R. Griffin, L. P. Shone, R. Barth, Y. Zhu, S. Schaffer, S. Ambrose, J. Roy, K. A. Poehling, K. M. Edwards, et al. The Impact of Conjugate Pneumococcal Vaccination on Routine Childhood Vaccination and Primary Care Use in 2 Counties Pediatrics, October 1, 2006; 118(4): 1394 - 1402. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Rathore PCV7: Impact on Invasive Pneumococcal Disease and Resistant S pneumoniae AAP Grand Rounds, August 1, 2006; 16(2): 13 - 14. [Full Text] [PDF] |
||||
![]() |
M.-C. C. Brandileone, S. T. Casagrande, M.-L. L. S. Guerra, R. C. Zanella, A.-L. S. S. Andrade, and J.-L. D. Fabio Increase in numbers of {beta}-lactam-resistant invasive Streptococcus pneumoniae in Brazil and the impact of conjugate vaccine coverage. J. Med. Microbiol., May 1, 2006; 55(Pt 5): 567 - 574. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Buckingham, J. A. McCullers, J. Lujan-Zilbermann, K. M. Knapp, K. L. Orman, and B. K. English Early Vancomycin Therapy and Adverse Outcomes in Children With Pneumococcal Meningitis Pediatrics, May 1, 2006; 117(5): 1688 - 1694. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Kyaw, R. Lynfield, W. Schaffner, A. S. Craig, J. Hadler, A. Reingold, A. R. Thomas, L. H. Harrison, N. M. Bennett, M. M. Farley, et al. Effect of Introduction of the Pneumococcal Conjugate Vaccine on Drug-Resistant Streptococcus pneumoniae N. Engl. J. Med., April 6, 2006; 354(14): 1455 - 1463. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Malley, A. Srivastava, M. Lipsitch, C. M. Thompson, C. Watkins, A. Tzianabos, and P. W. Anderson Antibody-Independent, Interleukin-17A-Mediated, Cross-Serotype Immunity to Pneumococci in Mice Immunized Intranasally with the Cell Wall Polysaccharide Infect. Immun., April 1, 2006; 74(4): 2187 - 2195. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Madsen, J. E. Bennett, and S. M. Downs The Role of Parental Preferences in the Management of Fever Without Source Among 3- to 36-Month-Old Children: A Decision Analysis Pediatrics, April 1, 2006; 117(4): 1067 - 1076. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Beall, M. C. McEllistrem, R. E. Gertz Jr., S. Wedel, D. J. Boxrud, A. L. Gonzalez, M.-J. Medina, R. Pai, T. A. Thompson, L. H. Harrison, et al. Pre- and postvaccination clonal compositions of invasive pneumococcal serotypes for isolates collected in the United States in 1999, 2001, and 2002. J. Clin. Microbiol., March 1, 2006; 44(3): 999 - 1017. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Flannery, R. T. Heffernan, L. H. Harrison, S. M. Ray, A. L. Reingold, J. Hadler, W. Schaffner, R. Lynfield, A. R. Thomas, J. Li, et al. Changes in Invasive Pneumococcal Disease among HIV-Infected Adults Living in the Era of Childhood Pneumococcal Immunization Ann Intern Med, January 3, 2006; 144(1): 1 - 9. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Pai, R. E. Gertz, and B. Beall Sequential Multiplex PCR Approach for Determining Capsular Serotypes of Streptococcus pneumoniae Isolates J. Clin. Microbiol., January 1, 2006; 44(1): 124 - 131. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-A. S. Kirkham, J. M. C. Jefferies, A. R. Kerr, Y. Jing, S. C. Clarke, A. Smith, and T. J. Mitchell Identification of Invasive Serotype 1 Pneumococcal Isolates That Express Nonhemolytic Pneumolysin J. Clin. Microbiol., January 1, 2006; 44(1): 151 - 159. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Rathore Emergence of Nonvaccine S pneumoniae Serotypes AAP Grand Rounds, October 1, 2005; 14(4): 43 - 44. [Full Text] [PDF] |
||||
![]() |
S. S. Huang, R. Platt, S. L. Rifas-Shiman, S. I. Pelton, D. Goldmann, and J. A. Finkelstein Post-PCV7 Changes in Colonizing Pneumococcal Serotypes in 16 Massachusetts Communities, 2001 and 2004 Pediatrics, September 1, 2005; 116(3): e408 - e413. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Malley, K. Trzcinski, A. Srivastava, C. M. Thompson, P. W. Anderson, and M. Lipsitch CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization PNAS, March 29, 2005; 102(13): 4848 - 4853. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. F. Smitherman, A. C. Caviness, and C. G. Macias Retrospective Review of Serious Bacterial Infections in Infants Who Are 0 to 36 Months of Age and Have Influenza A Infection Pediatrics, March 1, 2005; 115(3): 710 - 718. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Redelings, F. Sorvillo, P. Simon, and L. Mascola Declining Early Childhood Mortality From Invasive Pneumococcal Disease: The Impact of Vaccination Arch Pediatr Adolesc Med, February 1, 2005; 159(2): 195 - 196. [Full Text] [PDF] |
||||
![]() |
W. J. Durbin Pneumococcal Infections Pediatr. Rev., December 1, 2004; 25(12): 418 - 424. [Full Text] [PDF] |
||||
![]() |
R. Wise The relentless rise of resistance? J. Antimicrob. Chemother., August 1, 2004; 54(2): 306 - 310. [Abstract] [Full Text] [PDF] |
||||
![]() |
How Valuable Is Pneumococcal Vaccine? Journal Watch Pediatrics and Adolescent Medicine, June 14, 2004; 2004(614): 3 - 3. [Full Text] |
||||
![]() |
B. E. Gonzalez, K. G. Hulten, S. L. Kaplan, and E. O. Mason Jr. Clonality of Streptococcus pneumoniae Serotype 1 Isolates from Pediatric Patients in the United States J. Clin. Microbiol., June 1, 2004; 42(6): 2810 - 2812. [Abstract] [Full Text] [PDF] |
||||
![]() |
Pneumococcal Vaccine: More Good News Journal Watch Infectious Diseases, March 29, 2004; 2004(329): 8 - 8. [Full Text] |
||||
![]() |
Decline of Invasive Pneumococcal Disease in Young Children Journal Watch (General), March 9, 2004; 2004(309): 4 - 4. [Full Text] |
||||
![]() |
S. I. Pelton The Decline in Invasive Pneumococcal Disease Pediatrics, March 1, 2004; 113(3): 617 - 618. [Full Text] [PDF] |
||||


























